Print

ANRS VAC 04

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Lipopetide in Healthy HIV-1 uninfected Adults Participants

Trial Details:

I Completed
French National Agency for Research on AIDS and viral hepatitis (ANRS) November 21, 1996
LIPO-6 6 lipopeptides containing CTL epitopes from the Env, Gag and Nef B
LIPO-6 Protein
France 28
http://www.anrs.fr/